Your browser doesn't support javascript.
loading
CD24, not CD47, negatively impacts upon response to PD-1/L1 inhibitors in non-small-cell lung cancer with PD-L1 tumor proportion score < 50.
Ozawa, Yuichi; Harutani, Yuhei; Oyanagi, Jun; Akamatsu, Hiroaki; Murakami, Eriko; Shibaki, Ryota; Hayata, Atsushi; Sugimoto, Takeya; Tanaka, Masanori; Takakura, Toshiaki; Furuta, Katsuyuki; Okuda, Yuka; Sato, Kouichi; Teraoka, Shunsuke; Ueda, Hiroki; Tokudome, Nahomi; Kitamura, Yuka; Fukuoka, Junya; Nakanishi, Masanori; Koh, Yasuhiro; Yamamoto, Nobuyuki.
Afiliación
  • Ozawa Y; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Harutani Y; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Oyanagi J; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Akamatsu H; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Murakami E; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Shibaki R; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Hayata A; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Sugimoto T; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Tanaka M; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Takakura T; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Furuta K; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Okuda Y; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Sato K; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Teraoka S; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Ueda H; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Tokudome N; Oncology Center, Wakayama Medical University, Wakayama, Japan.
  • Kitamura Y; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Fukuoka J; Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Nakanishi M; Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Koh Y; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Yamamoto N; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
Cancer Sci ; 112(1): 72-80, 2021 Jan.
Article en En | MEDLINE | ID: mdl-33084148
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antígeno CD47 / Antígeno CD24 / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antígeno CD47 / Antígeno CD24 / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2021 Tipo del documento: Article País de afiliación: Japón